Skip to main content

Advertisement

Log in

Multidetector Computed Tomographic Urography (MDCTU): Its Practical Role in Diagnosis of Upper Tract Urothelial Cancer in Patients 50 years and Older with Different Types of Hematuria

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

MDCTU is a preferred method for the investigation of malignant lesions in the upper urinary tract. However, to decrease unnecessary radiation exposure the indications for the exam in different groups of patients should be assessed. In this study, we evaluated the role of MDCTU in patients older than 50 years who presented with different types of hematuria. In a retrospective manner, we assessed the radiologic reports of 173 patients ≥50 years who underwent MDCTU as a part of the evaluation for hematuria. To estimate the accuracy of MDCTU in the detection of upper urinary tract urothelial carcinoma (UUTUC) we compared MDCTU findings with the results of ureteroscopy. We also evaluated which factors can predict ureteroscopic confirmation of MDCTU-based diagnosis. In this list we also included diabetes mellitus and anticoagulant medications. As a result, 140 (103 males and 37 females) patients met the inclusion criteria. Mean patients' age was 69.7±16.98. Smokers and passive smokers comprised 38.6% and 26.4% of our patients, while 37.8% of our patients suffered from DM and 45% took anticoagulant medications. MDCTU suspected urothelial carcinoma in 17% (n=24) of our patients: UUTUC in eight and bladder urothelial carcinoma (BUC) in 16patients. Ureteroscopy had diagnosed UUTUC (with/without concurrent urothelial carcinoma of the bladder) in 9 patients: 6 with suspicious lesions in MDCTU and 3 additional patients with CIS/small low grade TCC. MDCTU had a sensitivity of 66.7%, specificity - 98.5%, positive predictive value - 75% and negative predictive value - 97.7%. The logistic regression model revealed five strong predictors for UUTUC: positive/atypical cytology, recurrent hematuria, MDCTU signs, age and Warfarin treatment. Finally a source of hematuria was diagnosed in 57% of patients, while MDCTU individual accuracy reached 42%. We found that MDCTU can effectively identify patients in whom further endoscopy is unnecessary. Otherwise, elder patients with positive/atypical cytology and recurrent microscopic hematuria, who have MDCTU signs and take Warfarin, should undergo endoscopic evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523–1525

  2. Roupreˆt M, Babjuk M, Compérat E et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059–1071

    Article  Google Scholar 

  3. Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64:639–653

    Article  Google Scholar 

  4. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

    Article  Google Scholar 

  5. Roupreˆt M, Babjuk M, Compérat E, Zigeuner R et al (2015) European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 68:868–879

    Article  Google Scholar 

  6. Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29(2):130–136

    Article  PubMed  Google Scholar 

  7. Raman JD, Ng CK, Scherr DS et al (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical Nephroureterectony. Eur Urol 57(6):1072–1079

    Article  PubMed  Google Scholar 

  8. Li WM, Shen JT, Li CC et al (2010) Oncologic outcomes following three different Aproaches to the distal ureter and bladder cuff in Nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 57(6):963–969

    Article  PubMed  Google Scholar 

  9. Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6):1224–1233

    Article  Google Scholar 

  10. Van Der Molen AJ, Cowan NC, Mueller-Lisse UG et al (2008) CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol 18(1):4–17

    Article  Google Scholar 

  11. Wang LJ, Wong YC, Chuang CK et al (2009) Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181(2):524–531

    Article  PubMed  Google Scholar 

  12. Wang LJ, Wong YC, Huang CC et al (2010) Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper tract in adults with hematuria. J Urol 183(1):48–55

    Article  PubMed  Google Scholar 

  13. Caoili EM, Cohan RH, Korobkin M et al (2002) Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology 222:353–360

    Article  PubMed  Google Scholar 

  14. Chlapoutakis K, Theocharopoulos N, YarmenitisS DJ (2010) Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol 73:334–338

    Article  PubMed  Google Scholar 

  15. Loo RK, Lieberman SF, Slezak JM et al (2013) Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc 88(2):129–138

    Article  PubMed  Google Scholar 

  16. O’Connor OJ, McSweeney SE, Maher MM (2008) Imaging of hematuria. Radiol Clin N Am 46:113–132

    Article  PubMed  Google Scholar 

  17. Edwards TJ, Dickinson AJ, Natale S, Gosling J, McGrath JS (2006) A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int 97:301–305

    Article  PubMed  Google Scholar 

  18. Cauberg EC1, Nio CY, de la Rosette JM, Laguna MP, de Reijke TM (2011) Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria? J Endourol 25(11):1733–1740

  19. Lisanti CJ1, Toffoli TJ, Stringer MT, DeWitt RM, Schwope RB (2014) CT evaluation of the upper urinary tract in adults younger than 50 years with asymptomatic microscopic hematuria: is IV contrast enhancement needed? AJR Am J Roentgenol 203(3):615–619

  20. Raman SP, Horton KM, Fishman EK (2012) Transitional cell carcinoma of the upper urinary tract: optimizing image interpretation with 3D reconstructions. Abdom Imaging 37:1129–1140

    Article  PubMed  Google Scholar 

  21. Johnson PT, Horton KM, Fishman EK (2010) Optimizing detectability of renal pathology with MDCT: protocols, pearls, and pitfalls. AJR 194:1001–1012

    Article  PubMed  Google Scholar 

  22. Woolcott CG1, Maskarinec G, Haiman CA, Henderson BE, Kolonel LN (2011) Diabetes and urothelial cancer risk: the multiethnic cohort study. Cancer Epidemiol 35(6):551–554

  23. Jung H, Gleason JM, Loo RK et al (2011) Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J Urol 185(5):1698–1703

    Article  PubMed  Google Scholar 

  24. Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164:1523–1525

    Article  CAS  PubMed  Google Scholar 

  25. van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP (2016) Significant role of lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis. J Urol 195(4):872–879

    Article  PubMed  Google Scholar 

  26. Caoili EM, Cohan RH, Inampudi P et al (2005) MDCT urography of upper tract urothelial neoplasms. AJR 184:1873–1881

    Article  PubMed  Google Scholar 

  27. Xu AD, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM (2010) Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR 195:959–965

    Article  PubMed  Google Scholar 

  28. Browne RF, Meehan CP, Colville J, Power R, Torreggiani WC (2005) Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics 25:1609–1627

    Article  PubMed  Google Scholar 

  29. Xu AD1, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM (2010) Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR Am J Roentgenol 195(4):959–965

  30. Khadra MH, Pickard RS, Charlton M et al (2000) A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 163(2):524–527

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergey Kravchick.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kravchick, S., Cherniavsky, E., Verchovsky, G. et al. Multidetector Computed Tomographic Urography (MDCTU): Its Practical Role in Diagnosis of Upper Tract Urothelial Cancer in Patients 50 years and Older with Different Types of Hematuria. Pathol. Oncol. Res. 25, 249–254 (2019). https://doi.org/10.1007/s12253-017-0333-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-017-0333-0

Keywords

Navigation